MacroGenics, Inc. (MGNX) Dividend History

Company News

• Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and Maplebear - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

  Johnson Fistel, LLP is investigating potential violations of federal and state laws by certain officers of MacroGenics, Apellis Pharmaceuticals, Teradata, and Maplebear. The investigations are related to alleged false and misleading statements made by the companies.

  GlobeNewswire Inc.

  Featured Companies: APLS CART TDC
• Demystifying Macrogenics: Insights From 14 Analyst Reviews

  Analysts' ratings for Macrogenics (NASDAQ:MGNX) over the last quarter vary from bullish to bearish, as provided by 14 analysts. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 6 4 0 0 Last 30D 1 0 0 0 0 1M Ago 0 2 3 0 0 2M Ago 0 0 0 0 0 3M Ago 3 4 1 0 0 In the assessment of 12-month price targets, analysts unveil insights for Macrogenics, presenting an average target of $17.57, a high estimate of $29.00, and a low estimate of $4.00. Highlighting a 7.18% decrease, the current average has fallen from the previous average price target of $18.93. Understanding Analyst Ratings: A Comprehensive Breakdown The standing of Macrogenics among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Kaveri Pohlman BTIG Lowers Buy $9.00 $24.00 Robert Burns HC Wainwright & Co. Lowers Neutral $4.00 $16.00 Peter Lawson Barclays Lowers Overweight $14.00 $25.00 Silvan Tuerkcan JMP Securities Lowers Market Outperform $16.00 $22.00 Etzer Darout BMO Capital Lowers Market Perform $8.00 $24.00 Stephen Willey Stifel Lowers Hold $7.00 $29.00 Yigal Nochomovitz Citigroup Raises Buy $25.00 $13.00 Silvan Tuerkcan JMP Securities Raises Outperform $22.00 $16.00 Robert Burns HC Wainwright & Co. Raises Neutral $16.00 $14.00 Etzer Darout BMO Capital Raises Outperform $24.00 $18.00 Stephen Willey Stifel Raises Buy $29.00 $17.00 Peter Lawson Barclays Raises Overweight $25.00 $23.00 Kaveri Pohlman BTIG Raises Buy $24.00 $12.00 Peter Lawson Barclays Raises Overweight $23.00 $12.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent ...Full story available on Benzinga.com

  Benzinga
• MacroGenics (MGNX) Q1 2024 Earnings Call Transcript

  MGNX earnings call for the period ending March 31, 2024.

  The Motley Fool
• MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates

  MacroGenics (MGNX) delivered earnings and revenue surprises of -188.46% and 58.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: SNDL